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Abstract. Left ventricular function and morphology have been shown to be im-
portant factors in clinical and pre-clinical cardiovascular disease.  In this paper 
we used atlas-based techniques to capture the full extent of morphological 
changes at end-diastole, end-systole and in a coupled functional atlas for 4547 
UK Biobank participants. The morphological differences between participants 
with risk factors for cardiovascular disease were tested using a logistic regression 
model. The result was compared to a model built from traditional mass and vol-
ume measures, and the strength of associations were tested using a Delong’s test. 
Atlas based models had stronger associations with risk factors than mass and vol-
ume parameters in most risk factors. The functional atlas showed better perfor-
mance than the separate end-diastole and end-systole atlases. 
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1 Introduction 
Cardiovascular disease is the leading cause of death worldwide, and is responsible for 
one in every four deaths [1]. Left ventricular (LV) function and morphology are im-
portant predictors of cardiac health. The LV changes shape, in a process known as re-
modeling, in response to a variety of clinical and pre-clinical disease processes [2].  
Previous work has demonstrated changes to LV morphology in those with higher blood 
pressure [3], higher fat mass [4] and smoking [5]. Many measures of changes to mor-
phology ignore large amounts of information, which is available in cardiac MRI. Sta-
tistical shape atlases capture the variety of LV morphological differences [6]. Atlases 
of the left ventricle have been used to quantify shape differences in participants of lon-
gitudinal studies [5,7]. While some previous studies have defined shape measures end-
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diastole (ED), e.g mass to volume ratio and sphericity, others are defined at end-systole 
(ES), e.g. ES volume index.   
UK Biobank is a longitudinal cohort study in the United Kingdom, which has per-
formed cardiac MRI on participants to examine the pre-clinical determinants of cardi-
ovascular disease. The cohort contains a subset of healthy participants who have no 
cardiovascular risk factors.  
Here, we extend previous work which showed that different shape atlases perform 
similarly in quantifying relationships with cardiovascular risk factors in UK Biobank, 
and are robust to different methods used in their construction. That work combined the 
scores from the first 20 modes of the separate ED and ES statistical shape models to 
quantify the relationships with risk factors. Here, we provide the following novel con-
tributions: 
1. We show that separate ED and ES statistical shape models have similar discrim-
ination power for the risk factors in UK Biobank, with ES having higher AUC, 
suggesting that LV morphology at ES may be more sensitive to the presence of 
risk factors.   
2. We test a functional atlas constructed by concatenating ED and ES shape mod-
els, thereby forming a coupled atlas which simultaneously describes coupled 
ED and ES shape variations. The functional atlas outperformed the separate ED 
and ES atlases for the diabetes and high cholesterol.  
2 Methods 
2.1 Imaging protocol and analysis 
The CMR protocol has been descripted previously in [8]. Briefly, all images were ac-
quired on a Siemens AERA 1.5T wide-BORE MRI scanner (Siemens Healthineers, 
Erlangen, Germany) using retrospectively gated cine balanced steady-state free preces-
sion breath-hold acquisitions. A short axis stack covering the left and right ventricles, 
as well as horizontal and vertical long axis slices and the left ventricular outflow track 
were acquired. The short axis images were manually contoured at ED and ES as re-
ported in [9]. All contouring was completed in accordance with Society of Cardiovas-
cular Magnetic Resonance recommendations as described in [9]. 
2.2 Atlas creation 
The atlas was constructed using the method described in [5]. Briefly, the manual con-
tours were extracted and fitted to a finite element model of the left ventricle using a 
least squares minimization.  The model was orientated using landmarks from the man-
ual contours to denote the LV apex, mitral valve inserts and right ventricle. The orien-
tated model was then fitted to the manual contours at ED and ES, creating participant 
specific models of the left ventricle. 
The participant specific models were then used to create three atlases (ED, ES and a 
functional atlas). For the individual ED and ES atlases each model was first aligned to 
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the average model using Procrustes (rotation and translation only). The coupled func-
tional atlas (EDES atlas) aligned at both ED and ES using the Procrustes calculated for 
the ED model. Principal component analysis (PCA) was then used to create each atlas. 
The ED and ES atlas describe shape at each individual time point. The functional atlas 
(EDES atlas) was created from participants coupled shapes where the surfaces were 
concatenated at ED and ES during the PCA, thus describes the variations in ED and ES 
that occur together.  
2.3 Statistics 
Z-scores were extracted for each participant in each mode of each of the three atlases. 
Associations between cardiovascular risk factors and shape were examined using a 
fivefold cross-validated logistic regression model in the R package Caret (R version 
3.5.1and Caret version 6.0-81). A separate model was created for each risk factor, 
which compared the healthy risk-free cohort and those with the particular risk factor. 
Participants with angina, and those who reported having had a heart attack were ex-
cluded from the analysis, except in the case of angina as a risk factor where only those 
who reported having a heart attack were excluded. Separate models were created for 
each atlas, as well as a mass and volume model. Area under the curve was recorded. 
Models were tested using the first 50 modes of variation from each atlas, and the final 
number of modes was selected where the area under the curve stabilized. Differences 
between the result of the mass volume model and the atlas models were tested using a 
Delong’s test and a Bonferroni corrected p-value of 0.0125 was considered significant. 
Risk factors of self-reported hypertension, high cholesterol, angina, smoking, diabetes 
as well as those who reported taking blood pressure medication or cholesterol medica-
tion at the time of imaging were selected for analysis.  
2.4 Visualization of the statistical models 
Let 𝑋 ∈ 𝑅𝑁×𝑃 be the centered data shape matrix with 𝑁 cases and 𝑃 shape dimensions. 
Principal component analysis of 𝑋 can be estimated by singular value decomposition 
of covariance of 𝑋, i.e. 𝐶 = 𝑋𝑇𝑋/(𝑁 − 1), as follows  
 𝐶 = Φ𝐿Φ𝑇  (1) 
where Φ ∈ 𝑅𝑃×𝑊 is an orthonormal matrix of the principal components, 𝐿 ∈ 𝑅𝑃×𝑃 is a 
diagonal matrix of eigenvalues (variances of each mode), and 𝑊 ≤ 𝑃 is the number of 
principal components or modes of variation. Let 𝑥 represent an individual column shape 
vector of 𝑋 with P shape dimensions. The normalized PCA z-scores for each participant 
in each mode can be defined as: 
 𝑇𝑧 = 𝑥Φ√𝐿
−1
 (2) 
The statistical model defines a regression score as: 
 𝑌 =  𝑇𝑧𝛽 =  𝑇√𝐿
−1
𝛽 (3) 
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Where Y is the score (log-odds in the logistic regression), 𝛽 ∈ 𝑅1×𝑄 are the coefficients 
of the statistical model where Q  is the number of variables included in the regression 
model.  We can define the following morphometric scores:  
  𝑌1  =  𝑇𝛽1 = 𝑋Φ𝛽1 = 𝑋𝑚                     (4) 
Where 𝛽1 is the normalized scaled coefficients (√𝐿
−1
𝛽/ |√𝐿
−1
𝛽|), and 𝑚 is a unit 
length morphometric shape vector. Thus we can visualize shape from the statistical 
model as  
 𝑥𝑀 = 𝑥𝑚𝑚
𝑇 = 𝑌1𝑚
𝑇  (5) 
The resulting logistic regression models were evaluated for all participants included 
in the model and visualized at the 5th and 95th percentiles.  
3 Results 
Table 1 shows the LV volumes and mass of participants with each risk factor, and the 
risk free cohort, as well the number in each group. Figure1 shows the first five PCA 
modes in the independent ED and ES atlases. The atlases were visually inspected to 
categorize mode shapes. Modes 1 of both atlases show that size accounts for 46% of 
the variation in LV morphology at ED and 43% at ES. Mode 2 shows variations in 
sphericity of the ventricle accounting for 15% and 10% at ED and ES respectively. The 
ED atlas shows variation in the mitral valve tilt in modes 3, 4 and apical sphericity in 
mode 5. The ES atlas shows variation in global wall thickness in mode 3 and mitral 
valve tilt in modes 4 and 5.  
Table 1. Cardiovascular function and number of participants in each risk factor or cohort in-
cluded in analysis. LV volumes and mass are reported as mean ± standard deviation 
  n Male  LV EDV 
(ml) 
LV ESV(ml) LV mass (g) 
Risk free co-
hort 
751 344 143.74 ± 34.32 58.85 ± 18.26 85.42 ± 24.00 
Blood pres-
sure medica-
tion 
885 498 145.86 ± 33.02 59.29 ± 19.84 96.06 ± 24.86 
Cholesterol 
Medication 
822 539 146.08 ± 32.88 59.86 ± 18.86 96.06 ± 24.62 
High Blood 
pressure 
1100 621 146.48 ± 31.49 59.85 ± 19.64 97.02 ± 25.67 
High Choles-
terol 
276 170 143.48 ± 31.49 58.85 ± 18.31 94.06 ± 24.09 
Angina 83 51 150.55 ± 31.04 60.98 ± 18.75 98.94 ± 24.77 
Diabetes 207 121 144.82 ± 33.68 60.83 ± 20.32 97.29 ± 24.76 
Smoking 279 151 145.43 ± 33.20 61.20 ± 18.94 93.04 ±  24.17 
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Figure 2 shows the first five modes of variation in the functional atlas. Mode 1 shows 
variation in size at both ED and ES, accounting for 39% of the variation in the LV 
morphology of the participants. Mode 2 shows changes in sphericity at both ED and ES 
which explains 11% of the variation in LV morphology across the participants. Mode 
3 shows a variation in mitral valve tilt at ED similar to that seen in mode 4 of the ED 
atlas, and variation at wall thickness at ES. Mode 4 shows variation in mitral valve tilt 
at both ED and ES. Mode 5 can be characterized as variations in apical sphericity at ED 
and mitral valve tilt at ES.  
 
Fig. 1. The first five modes of the ED and ES atlas at the 5th and 95th percentile. The variance 
explained by each mode is also displayed. Septum is on the left. 
 
Fig. 2. The first five modes of the function atlas at the 5th and 95th percentile. The variance ex-
plained by each mode is also displayed. Septum is on the left. 
Figure 3 shows the area under the curve for each risk factor, with each of the four 
logistic regression models, varying the number of mode scores included. 40 modes were 
chosen as an appropriate cut off for inclusion in the statistical model as it allowed for 
the AUC to stabilize in all variables considered.  
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Fig. 3. Cumulative area under the curve plots in a logistic regression model with 1 to 50 modes 
included. Black is the area under the curve for a mass volume model, blue is ED, red is ES and 
green is the functional atlas EDES. 
The results of the logistic regression models are shown in Table 2 and in Figure 4. 
Table 2 shows the area under the curve for each model and the result of the Delong’s 
test between the mass volume model and the atlas. The atlases had a significantly higher 
association with cholesterol lowering medication, blood pressure medication, diabetes, 
high blood pressure and high cholesterol than LV mass and volume. 
 
Fig. 4. Density plots of scores from logistic regression models with 40 modes. The 
risk free cohort are shown in blue and the risk factor positive cases are shown in orange.  
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Table 2. Area under the curve for fivefold cross validation logistic regression models for each 
risk factor. Mass volume model (MV) included LV EDV, ESV and mass, each model built from 
an atlas used the first 40 modes. * p<0.0125 for Delong’s test 
 
MV ED ES EDES 
Cholesterol lowering medication 0.67 0.74* 0.75* 0.76* 
Blood pressure medication 0.67 0.74* 0.75* 0.76* 
Smoking 0.61 0.65 0.63 0.68 
Diabetes 0.69 0.73 0.76* 0.77* 
Angina 0.67 0.66 0.71 0.73 
High Blood pressure 0.68 0.74* 0.74* 0.76* 
High Cholesterol 0.65 0.72* 0.70 0.73* 
 
 
Fig. 5. Morphometric risk factor shapes from the logistic regression model of the functional atlas 
at the 5th and 95th percentiles. The average shapes were drawn with the color scale shown. Yellow 
denotes an outward displacement of the surface, and blue an inward displacement. View point is 
from the anterior with the septum on the left.  
4 Discussion  
The results of this study indicate a strong association between cardiovascular risk fac-
tors and LV morphology. Three separate atlases were tested and all showed strong as-
sociation cholesterol lowering medication, blood pressure medication and high blood 
pressure. The ED model also showed a strong association with high cholesterol, and 
the functional atlas (EDES) showed a strong association with diabetes, high blood pres-
sure and high cholesterol. The results suggest that LV morphology changes at both ED 
and ES in the presence of risk factors. Previously [7]  used a five-fold cross-validated 
logistic regression to test the association of risk factors to two atlases created using 
different methods. The method used in this paper was similar to the surface atlas in the 
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previous work; which built a logistic regression model with the first 20 mode scores at 
ED and ES combined from independent atlases. Our current study showed similar area 
under the curves for the risks factors studied, however the ES model and EDES model 
described in this paper result in a larger area under the curve than ED in most cases. 
The functional atlas performed similarly to the previous combined score analysis.  
The functional atlases was created from the participants’ specific shapes at ED and 
ES, thus having the advantage of describing variation in LV morphology that occur at 
ED and ES in the same participant. Thus building a logistic regression from this atlas 
has the advantage of making sure morphological features selected by the logistic re-
gression model at ED and at ES can occur in the same participant.  
The study is limited by the cross-sectional nature of UK biobank. However in the 
future, the shape atlases could be compared with follow-up information, such as cardiac 
events to better understand remodeling in pre-clinical cardiovascular disease.  
5 Conclusions 
Shape atlases of LV morphology have a stronger relationship with the cardiovascular 
risk factors of high blood pressure, high cholesterol, and diabetes, than standard 
measures of mass and volume. The functional atlas has the largest area under the curve, 
and provides accurate simultaneous deformations at ED and ES.   
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